BSE Live
Dec 03, 16:02Prev. Close
5640.65
Open Price
5570.70
Bid Price (Qty.)
5575.00 (5)
Offer Price (Qty.)
5651.40 (5)
NSE Live
Dec 03, 15:41Prev. Close
5638.50
Open Price
5640.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
5647.50 (22)
| Profit & Loss account of Alkem Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | |
| 12 mths | 12 mths | ||
| INCOME | |||
| Revenue From Operations [Gross] | 3,778.10 | 3,143.12 | |
| Less: Excise/Sevice Tax/Other Levies | 116.51 | 105.22 | |
| Revenue From Operations [Net] | 3,661.59 | 3,037.90 | |
| Total Operating Revenues | 3,743.35 | 3,130.75 | |
| Other Income | 181.04 | 169.02 | |
| Total Revenue | 3,924.39 | 3,299.77 | |
| EXPENSES | |||
| Cost Of Materials Consumed | 862.03 | 758.94 | |
| Purchase Of Stock-In Trade | 862.25 | 676.88 | |
| Operating And Direct Expenses | 0.00 | 0.00 | |
| Changes In Inventories Of FGWIP And Stock In Trade | -33.68 | -60.73 | |
| Employee Benefit Expenses | 645.87 | 520.15 | |
| Finance Costs | 81.11 | 93.08 | |
| Depreciation And Amortisation Expenses | 70.94 | 51.89 | |
| Other Expenses | 985.05 | 811.06 | |
| Total Expenses | 3,473.57 | 2,851.27 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 450.82 | 448.50 | |
| Exceptional Items | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 450.82 | 448.50 | |
| Tax Expenses-Continued Operations | |||
| Current Tax | 87.45 | 94.53 | |
| Less: MAT Credit Entitlement | 79.00 | 92.99 | |
| Deferred Tax | 30.74 | 7.96 | |
| Other Direct Taxes | 0.00 | 0.00 | |
| Total Tax Expenses | 59.23 | 9.50 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 391.59 | 439.00 | |
| Profit/Loss From Continuing Operations | 391.59 | 439.00 | |
| Profit/Loss For The Period | 391.59 | 439.00 | |
| Minority Interest | 0.00 | 0.00 | |
| Consolidated Profit/Loss After MI And Associates | 391.59 | 439.00 | |
| OTHER ADDITIONAL INFORMATION | |||
| EARNINGS PER SHARE | |||
| Basic EPS (Rs.) | 33.00 | 37.00 | |
| Diluted EPS (Rs.) | 33.00 | 37.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | |||
| Equity Share Dividend | 47.83 | 23.91 | |
| Tax On Dividend | 8.85 | 4.06 |
24.11.2025
Alkem Lab Standalone September 2025 Net Sales at Rs 2,542.03 crore, down 11.49% Y-o-Y
18.11.2025
17.11.2025
Neutral ALKEM Laboratories; target of Rs 5560: Motilal Oswal
11.11.2025
24.11.2025
Alkem Lab Standalone September 2025 Net Sales at Rs 2,542.03 crore, down 11.49% Y-o-Y
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
12.08.2025
Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%
12.06.2025
Alkem Lab Standalone March 2025 Net Sales at Rs 2,044.94 crore, down 13.55% Y-o-Y
12.07.2023
Alkem Laboratories Q1 PAT seen up 135.1% YoY to Rs 299.7 cr: Nirmal Bang
17.10.2018
Alkem Labs Q2 PAT may dip 30.2% YoY to Rs. 220 cr: HDFC Securities
20.04.2018
Alkem Labs Q4 PAT may dip 1.5% YoY to Rs. 130 cr: HDFC Securities
12.04.2018
Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key